This pragmatic randomized controlled trial aimed to assess the effect of a passive display of artificial intelligence (AI)-based predictive analytics on hours free of clinical deterioration events ...
Whole-blood transfusion has recently gained favor in the management of severe hemorrhage; however, data from large clinical trials evaluating its clinical effectiveness and safety are lacking. We ...
Science faces a reproducibility crisis, and public trust in science declines when large clinical trials, which had been qualified by promising preclinical studies, fail. While some clinical trial ...
A large real-world clinical trial has found that a generative AI-powered support tool used to support frontline clinicians was safe and improved the quality of clinical decision-making, but did not ...
A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...
As cell and gene therapies (CGTs) continue to advance, they have unique developmental features that may require innovation in ...
STOCKHOLM, SWEDEN - June 17, 2026. Gesynta Pharma AB, a Swedish clinical stage pharmaceutical company focusing on chronic ...
Gesynta Pharma has announced that 50% of the target 190 patients have been randomized in its Phase 2 clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results